ArticleTranslational cancer research2022

Efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy in the treatment of relapsed and refractory multiple myeloma: a systematic-review and meta-analysis of clinical trials.

Jingjing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.